P1000: JUVENILE MYELOMONOCYTIC LEUKEMIA (JMML) INHIBITS T CELL PROLIFERATION VIA THE ECTONUCLEOTIDASE CD39 AND THE PURINERGIC NETWORK

por Rajak, Jovana, Koleci, Naile, Mesesan, Andreea, Flotho, Christian, Niemeyer, Charlotte, Bengsch, Bertram, Erlacher, Miriam
Publicado 2023

S206: ONCO-FETAL REPROGRAMMING DRIVES HIGH-RISK JUVENILE MYELOMONOCYTIC LEUKEMIA, WHICH CAN BE TARGETED BY ANTI-CD52 TREATMENT

por Hartmann, Mark, Schönung, Maximilian, Rajak, Jovana, Hey, Joschka, Maurer, Valentin, Hai, Ling, Staeble, Sina, Langstein, Jens, Bauer, Katharina, Hakobyan, Mariam, Jardine, Laura, Bohler, Sheila, Vonficht, Dominik, Maag, Abdul-Habib, Lebrecht, Dirk, Bernt, Kathrin, Rölz, Roland, Boch, Tobias, Khabirova, Eleonora, Lutsik, Pavlo, Haas, Simon, Haniffa, Muzlifah, Behjati, Sam, Mallm, Jan-Philipp, Buske, Christian, Milsom, Michael, Fröhling, Stefan, Bonder, Marc-Jan, Plass, Christoph, Niemeyer, Charlotte, Flotho, Christian, Erlacher, Miriam, Schlesner, Matthias, Lipka, Daniel B.
Publicado 2023